New diabetes drug tested for safety during dangerous lows
NCT ID NCT06982846
Summary
This study is testing a new weekly medicine called retatrutide to see if it helps people with type 2 diabetes recover faster from episodes of dangerously low blood sugar. About 78 participants will receive either the real medicine or a placebo for 16 weeks. Researchers will then measure how quickly their blood sugar returns to a safe level during a controlled test.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for TYPE 2 DIABETES MELLITUS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Medizinische Universität Graz
Graz, 8010, Austria
Conditions
Explore the condition pages connected to this study.